TP53 and neoplasm: In a cohort of patients with oropharyngeal squamous cell carcinoma (OPSCC), matched somatic variants identified in both tumor tissue and plasma cfDNA—mainly involving TP53 and FBXW7—were observed exclusively in nonresponders or patients with persistent disease.